The impact of lifestyle modification on the health-related quality of life of patients with reflux esophagitis receiving treatment with a proton pump inhibitor

American Journal of Gastroenterology

Volumn 104, Issue 5, 2009, Pages 1106-1111

  Kinoshita, Yoshikazu ^a   Ashida, Kiyoshi ^b   Miwa, Hiroto ^c   Hongo, Michio ^d  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^b SAISEIKAI NAKATSU HOSPITAL   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE; PROTON PUMP INHIBITOR; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY POSITION; CARBONATED BEVERAGE; CLINICAL ASSESSMENT; COFFEE; DIET; DRUG EFFECT; FEMALE; FOOD INTAKE; HEAD POSITION; HEALTH SURVEY; HUMAN; JAPANESE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; OBSERVATIONAL STUDY; PHYSICAL CAPACITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REFLUX ESOPHAGITIS; SCORING SYSTEM; SHORT FORM 8; SMOKING CESSATION; TREATMENT DURATION; TREATMENT RESPONSE; BEHAVIOR THERAPY; COHORT ANALYSIS; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; ESOPHAGOSCOPY; FOLLOW UP; HOSPITALIZATION; JAPAN; LIFESTYLE; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATIENT COMPLIANCE; PROBABILITY; PSYCHOLOGICAL ASPECT; REFERENCE VALUE; RISK ASSESSMENT; TREATMENT OUTCOME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; BEHAVIOR THERAPY; COHORT STUDIES; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ESOPHAGITIS, PEPTIC; ESOPHAGOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; LIFE STYLE; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PROBABILITY; PROTON PUMP INHIBITORS; QUALITY OF LIFE; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 66949122519     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.77     Document Type: Article

References (18)

1. Dent J, El-Serag HB, Wallander MA et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005;54:710-7.
2. Wong BC, Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin Gastroenterol Hepatol 2006;4:398-407.
3. El-Serag HB. Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol 2007;5:17-26.
4. DeVault KR, Castell DO, American College of Gastroenterology. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 2005;100:190-200.
5. Bretagne JF, Honnorat C, Richard-Molard B et al. Perceptions and practices on the management of gastro-oesophageal reflux disease: results of a national survey comparing primary care physicians and gastroenterologists. Aliment Pharmacol Ther 2007;25:823-33.
6. Kaltenbach T, Crockett S, Gerson LB. Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Arch Intern Med 2006;166:965-71.
7. Hongo M, Kinoshita Y, Miwa H et al. The demographic characteristics and health-related quality of life in a large cohort of reflux esophagitis patients in Japan with reference to the effect of lansoprazole: the REQUEST study. J Gastroenterol 2008;43:920-7.
8. Lundell LR, Dent J, Bennett JR et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172-80.
9. Hongo M. Minimal changes in reflux esophagitis: red ones and white ones. J Gastroenterol 2006;41:95-9.
10. Fukuhara S, Suzukamo Y. Manual of the SF-8 Japanese version: Institute for Health outcomes & Process Evaluation Research, Kyoto, 2004 (in Japanese).
11. Hongo M, Miwa H, Ashida K et al. The development of a new questionnaire of health-related quality of life for reflux esophagitis. Prog Med 2008;28:2219-24 (in Japanese).
12. Kinoshita Y. Review article: treatment for gastro-oesophageal reflux disease-lifestyle advice and medication. Aliment Pharmacol Ther 2004;20 (Suppl 8): 19-23.
13. Ledeboer M, Masclee AA, Batstra MR et al. Effect of cholecystokinin on lower oesophageal sphincter pressure and transient lower oesophageal sphincter relaxations in humans. Gut 1995;36:39-44.
14. Wright LE, Castell DO. The adverse effect of chocolate on lower esophageal sphincter pressure. Am J Dig Dis 1975;20:703-7.
15. Allen ML, Mellow MH, Robinson MG et al. The effect of raw onions on acid reflux and reflux symptoms. Am J Gastroenterol 1990;85:377-80.
16. Iwakiri K, Kobayashi M, Kotoyori M et al. Relationship between postprandial esophageal acid exposure and meal volume and fat content. Dig Dis Sci 1996;41:926-30.
17. Holloway RH, Hongo M, Berger K et al. Gastric distention: a mechanism for postprandial gastroesophageal reflux. Gastroenterology 1985;89:779-84.
18. Pehl C, Waizenhoefer A, Wendl B et al. Effect of low and high fat meals on lower esophageal sphincter motility and gastroesophageal reflux in healthy subjects. Am J Gastroenterol 1999;94:1192-6.